Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
General22 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News13 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
Noosa News19 hours agoRoaring jet boats to return to Victoria for first time in 15 years
-
General13 hours agoHackers release Qantas customers’ data on dark web